.Merck defeats earnings requirements, rears purchases overview on tough requirement for best medicines like Keytruda CNBCMerck & Co. (MRK United States) Beats Profit Estimates as Keytruda Sales Growth BloombergMerck Sell: Pharma Giant Posts Powerful Outcomes, But Expectation Falls Short Entrepreneur's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps earnings as well as purchases expectations amid Keytruda strength, however gives blended full-year expectation MarketWatch.